Home > Healthcare > Medical Devices > Therapeutic Devices > Neuromuscular Electric Stimulator Market

Neuromuscular Electric Stimulator Market Size

  • Report ID: GMI11802
  • Published Date: Oct 2024
  • Report Format: PDF

Neuromuscular Electric Stimulator Market Size

The global neuromuscular electric stimulator market size was valued at USD 381.7 million in 2023 and is expected to exhibit growth at a CAGR of 9.1% from 2024 to 2032. The market is experiencing significant growth driven by advancements in technology, increasing prevalence of musculoskeletal disorders, and rising demand for effective rehabilitation solutions.

 

Recent trends highlight a surge in the adoption of these devices across various healthcare settings, including sports medicine and physical therapy. For instance, the market has seen innovations in device functionality, such as the integration of smart technology and wearable sensors, enhancing patient outcomes and user experience.

 

Additionally, increasing focus on personalized and home-based treatments, driven by advancements in portable neuromuscular stimulators are other factors propelling the market progression. Companies such as the Omron have introduced advanced models featuring wireless technology and customizable programs to cater to individual therapy needs. Furthermore, regulatory approvals and endorsements from reputable organizations, such as the U.S. FDA and European Medicines Agency (EMA), have bolstered market confidence. The combination of technological innovation, growing awareness, and a shift towards home-based care is shaping the future of the neuromuscular electric stimulator market, creating new opportunities for growth and development in this sector.

 

A neuromuscular electric stimulator (NMES) is a medical device that uses electrical impulses to stimulate muscle contractions. It is primarily used for muscle rehabilitation, strengthening, and pain management. NMES operates by delivering controlled electrical impulses to nerves, which induce muscle contractions similar to natural movements. This therapy is frequently employed in physical therapy to address muscle atrophy, enhance circulation, and support recovery following injury or surgery.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global neuromuscular electric stimulator industry was valued at USD 381.7 million in 2023 and is expected to grow at a 9.1% CAGR from 2024 to 2032, driven by technological advancements and increasing demand for rehabilitation solutions.

The handheld neuromuscular stimulators segment generated USD 309.8 million in 2023, favored for their convenience and ease of use compared to bulky stationary devices.

North America neuromuscular electric stimulator industry recorded USD 157.3 million in 2023 and is anticipated to grow at an 8.4% CAGR from 2024 to 2032, supported by a well-established healthcare infrastructure and increasing incidence of musculoskeletal disorders.

Key players in the industry include AxioBionics LLC, Enovis Corporation, Ibramed Medical, MTR + Vertriebs GmbH, NeuroMetrix, Inc., OMRON Corporation, Ottobock, RS Medical, Sky Medical Technology Ltd., and Verity Medical Ltd.

Neuromuscular Electric Stimulator Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 134
 Download Free Sample